Poverty is an important patient-reported outcome of therapy and a potential predictor of outcome disparities in pediatric cancer. We previously identified that nearly 30% of pediatric cancer families experience household material hardship (HMH), a concrete measure of poverty including food, energy, or housing insecurity, during the first 6 months of chemotherapy. We conducted a follow-up survey in a subcohort of these families at least 1 year off-therapy and found that 32% reported HMH in early survivorship. Persistently high concrete resource needs off-therapy may have significance for child health and quality of life, and thus represent targets for future investigation.
INTRODUCTION
Recent literature has identified social determinants of healthnonbiological correlates of health outcomes such as poverty, financial burden, or medication adherence-as targets for investigation in the early childhood cancer treatment setting. [1] [2] [3] [4] [5] In 2016, the strong correlation between poverty and inferior pediatric health outcomes prompted the American Academy of Pediatrics to recommend universal pediatric poverty screening. 6 Concurrently, the Children's Oncology Group and American Psychosocial Oncology Society endorsed new standards acknowledging financial strain as an important patientreported outcome and "strongly recommended" systematic screening from diagnosis into survivorship or bereavement. 7, 8 Household material hardship (HMH), including food, housing, or energy insecurity, is an appealing concrete measure of financial burden as it is associated with health outcomes in general pediatrics 9 and can be ameliorated through systematic linkage with government or community resources. 10, 11 We previously described the frequency of HMH in a cohort of newly diagnosed pediatric cancer families and found that, in concert with national data, 20% were experiencing HMH at diagnosis. 1, 12, 13 This increased to nearly 30% following 6 months Abbreviations: FPL, federal poverty level; HMH, household material hardship; IQR, interquartile range; Onc EIS, Oncology Economic Impact Study of chemotherapy. 1 We now sought to describe the frequency of HMH and financial burden in early survivorship and hypothesized that both patient-reported outcomes would be prevalent.
METHODS
We utilized a subcohort of the previously published Oncology Economic Impact Study (Onc EIS) to conduct a cross-sectional "Long-Term 
Study population
Eligibility criteria for T3 included (1) Onc EIS participant who completed baseline and 6 month surveys and agreed to future contact, (2) child at least 1 year off-therapy, (3) child neither relapsed nor died, and (4) primary team permission to approach.
Data collection
Of the N = 99 Onc EIS cohort, 68 (69%) families were eligible for T3.
Eligible families were contacted by a research assistant and asked to complete a one-time survey either in-person or via telephone; questions were read aloud. The 77-item T3 survey included domains of (1) demographics, (2) HMH, (3) employment and income, and (4) financial impact.
Operational definition of variables
In concert with prior publications, we defined a family as having HMH if they endorsed at least one unmet need including food, energy, or housing. 1, 9 Year-specific federal poverty levels (FPLs) were based on the Department of Health and Human Services Poverty Guidelines and calculated as follows: baseline family income was divided by the yearspecific poverty guideline for household size and multiplied by 100 to achieve percentage of FPL. 14 
Statistical methods
We summarized child, family, and financial characteristics using descriptive statistics including frequencies, proportions, medians, interquartile ranges (IQRs), and ranges. To compare baseline characteristics between T3 participants and those either ineligible for T3 or who declined actively or passively to participate, we used Fisher's exact test and Wilcoxon rank sum test to test categorical and continuous variables, respectively. Two-sided P values <0.05 were considered significant. Analyses were conducted using SAS v. 9.4 for Windows (SAS Institute, Cary, NC).
RESULTS
Of the 68 families eligible for T3, 15 were unreachable, 53 were successfully contacted, and 52 consented to participate (76% response rate). The T3 survey was administered at least 1 year from the completion of therapy, a median of 2.6 years (1.3-3.7) from diagnosis; 42 (81%) surveys were administered by phone and 10 (19%) in-person.
To assess potential biases between T3 participants (N = 52) and nonparticipants (including those ineligible to participate or who declined to participate) (N = 47), we compared baseline characteristics between the two groups. While demographics at time of diagnosis did not differ statistically between T3 participants and nonparticipants, we noted a trend toward higher socioeconomic status in T3 families.
At diagnosis, fewer T3 families reported HMH (15% vs. 26%; Fisher's exact test P = 0.22) and more T3 families reported at least a college degree (83% vs. 68%; P = 0.1). Child disease characteristics did not differ statistically between groups, nor were there notable trends. 
TA B L E 1
Baseline child and family characteristics of long-term follow-up survey (T3) respondents (N = 52
T3 PARENT AND HOUSEHOLD CHARACTERISTICS AT BASELINE
A majority of parents were white (81%) and college educated (83%) ( Table 1) . Nearly all (96%) were employed with a median household income of $101,012 (IQR $72,690-$182,500), above the $83,700 median household income for families in Massachusetts. 15 
HOUSEHOLD MATERIAL HARDSHIP
At diagnosis, 15% of families reported HMH. This increased to 33% after 6 months of chemotherapy, and persisted at 33% at T3 (Fig. 1) .
Family-reported food and energy insecurity, for which comparative national data exist, were significantly lower at baseline (8% each) than national averages (20% and 18%, respectively). 12,13 
DISCUSSION
We previously reported that 29% of pediatric oncology families at a large referral center experienced food, housing, or energy insecurity following 6 months of chemotherapy. 1 Our data represent a single center and a relatively small, socioeconomically advantaged cohort. This clear limitation may bias our findings toward underestimating the prevalence of HMH in a more socioeconomically diverse pediatric cohort. While administered at least 1 year off-therapy, the T3 survey was not given at a standardized timepoint that limits our ability to describe time-specific outcomes. These data provide a first descriptive highlight of a seemingly significant problem in pediatric oncology.
Poverty-including HMH-is associated with inferior general pediatric health outcomes including metabolic syndrome, cardiovascular effects, delayed development, chronic illness, and injury. 6, 7, 9, [16] [17] [18] [19] It is plausible that household poverty in the off-therapy setting may have implications for child health in survivorship-including adherence to recommended screening or risk of late effects. Over one in three children from middle class families appear to be living in homes with unmet basic resource needs during early cancer survivorship.
Further investigation of the prevalence and impact of such need is warranted.
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